Alert: Rating Downgrade (1/12/24)-Fate Therapeutics Inc (NASDAQ: FATE).
Stock Rating Downgrade The Value Trend Rating for Fate Therapeutics Inc (NASDAQ: FATE) weakened recently from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our […]